Orasis Pharmaceuticals has announced the availability of Starter Packs of Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% to broaden access for patients seeking a flexible option to manage their presbyopia.

Each Qlosi Starter Pack includes 10 vials, 2 daily doses for 5 days of treatment, along with a patient progress tracker and referral card that are shipped directly to the prescribing eyecare practitioner (ECP) for patient dissemination.